Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.57 USD | -2.22% | -1.40% | +21.94% |
Apr. 19 | Lake Street Starts Cellebrite DI With Buy Rating, $13 Price Target | MT |
Apr. 01 | BofA Securities Adjusts Cellebrite DI Price Target to $13 From $12, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.94% | 2.22B | |
+4.97% | 2,894B | |
+1.58% | 80.94B | |
+1.06% | 75.01B | |
-16.29% | 52.08B | |
+27.34% | 48.93B | |
-27.55% | 44.85B | |
+17.86% | 40.49B | |
+53.51% | 36.29B | |
-10.81% | 24.36B |
- Stock Market
- Equities
- CLBT Stock
- News Cellebrite DI Ltd.
- BofA Securities Adjusts Cellebrite DI Price Target to $13 From $12, Maintains Buy Rating